Cargando…

A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease is a huge cause of chronic liver failure around the world. This condition has become more prevalent as rates of metabolic syndrome, type 2 diabetes, and obesity have also escalated. The unfortunate outcome for many people is liver cirrhosis that warrants transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Erin Nicole, Dogan, Murat, Watkins, Christine, Bajwa, Amandeep, Eason, James D., Kuscu, Canan, Kuscu, Cem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569609/ https://www.ncbi.nlm.nih.gov/pubmed/36233107 http://dx.doi.org/10.3390/ijms231911805

Ejemplares similares

MicroRNAs: Novel Targets in Hepatic Ischemia–Reperfusion Injury
por: Ingram, Holly, et al.
Publicado: (2022)

Mitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer
por: Patel, Prisha S., et al.
Publicado: (2022)

FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury
por: Rousselle, Thomas V., et al.
Publicado: (2020)

Integrative Analyses of Circulating Small RNAs and Kidney Graft Transcriptome in Transplant Glomerulopathy
por: Kuscu, Canan, et al.
Publicado: (2021)

Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury
por: Namwanje, Maria, et al.
Publicado: (2021)

Circulating microRNA Profiles for Premature Cardiovascular Death in Patients with Kidney Failure with Replacement Therapy
por: Kuscu, Canan, et al.
Publicado: (2023)

Defatting strategies in the current era of liver steatosis
por: Mazilescu, Laura Ioana, et al.
Publicado: (2021)

Transgene-specific host responses in cutaneous gene therapy: the role of cells expressing the transgene
por: Zhang, Zhenghua, et al.
Publicado: (2009)

Modeling convection-diffusion-reaction systems for microfluidic molecular communications with surface-based receivers in Internet of Bio-Nano Things
por: Kuscu, Murat, et al.
Publicado: (2018)

Fluorescent Molecules as Transceiver Nanoantennas: The First Practical and High-Rate Information Transfer over a Nanoscale Communication Channel based on FRET
por: Kuscu, Murat, et al.
Publicado: (2015)

Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
por: Singh, Ritambhara, et al.
Publicado: (2015)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

tRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner
por: Kuscu, Canan, et al.
Publicado: (2018)

The utility of 1.5 tesla MR-guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor – Case reports and review of the literature
por: Yavas, Guler, et al.
Publicado: (2022)

D-DSC: Decoding Delay-based Distributed Source Coding for Internet of Sensing Things
por: Aktas, Metin, et al.
Publicado: (2018)

Evaluating the Functional Characteristics of Certain Insect Flours (Non-Defatted/Defatted Flour) and Their Protein Preparations
por: Zielińska, Ewelina
Publicado: (2022)

Lesions in the thymus and bone marrow in chicks with experimentally induced chicken infectious anemia disease
por: Kuscu, Burak, et al.
Publicado: (2008)

A Real-Time Apple Grading System Using Multicolor Space
por: Toylan, Hayrettin, et al.
Publicado: (2014)

Case-finding strategies in non-alcoholic fatty liver disease
por: Boursier, Jerome, et al.
Publicado: (2020)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Ex-Vivo Pharmacological Defatting of the Liver: A Review
por: Goumard, Claire, et al.
Publicado: (2021)

Transcriptional and Epigenetic Regulation of KIAA1199 Gene Expression in Human Breast Cancer
por: Kuscu, Cem, et al.
Publicado: (2012)

Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis
por: Aoudjehane, Lynda, et al.
Publicado: (2020)

Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
por: Kuscu, Ozlem Ozkan, et al.
Publicado: (2022)

Fabrication and microfluidic analysis of graphene-based molecular communication receiver for Internet of Nano Things (IoNT)
por: Kuscu, Murat, et al.
Publicado: (2021)

Causes of erectile dysfunction in non-alcoholic fatty liver disease
por: Tarik Kani, Haluk, et al.
Publicado: (2021)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
por: Teng, Tieshan, et al.
Publicado: (2022)

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia
por: Banach, Anna, et al.
Publicado: (2019)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Physicochemical and Techno-Functional Properties of Dried and Defatted Porcine Liver
por: Abril, Blanca, et al.
Publicado: (2022)

Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity
por: Hatipoğlu, Nihal, et al.
Publicado: (2016)

Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9
por: Qin, Peiwu, et al.
Publicado: (2017)

Myo-Inositol Safety in Pregnancy: From Preimplantation Development to Newborn Animals
por: Kuşcu, Nilay, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease
por: BİNGÜL, İlknur, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_69t0nhg0fflelp952psigclkrl